These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1193 related items for PubMed ID: 18566103
1. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes. Nonaka K, Saio M, Suwa T, Frey AB, Umemura N, Imai H, Ouyang GF, Osada S, Balazs M, Adany R, Kawaguchi Y, Yoshida K, Takami T. J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103 [Abstract] [Full Text] [Related]
2. Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. Umemura N, Saio M, Suwa T, Kitoh Y, Bai J, Nonaka K, Ouyang GF, Okada M, Balazs M, Adany R, Shibata T, Takami T. J Leukoc Biol; 2008 May; 83(5):1136-44. PubMed ID: 18285406 [Abstract] [Full Text] [Related]
12. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity. Hwang KS, Cho WK, Yoo J, Seong YR, Kim BK, Kim S, Im DS. Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962 [Abstract] [Full Text] [Related]
13. In vitro and in vivo antitumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes. Fox BA, Spiess PJ, Kasid A, Puri R, Mulé JJ, Weber JS, Rosenberg SA. J Biol Response Mod; 1990 Oct; 9(5):499-511. PubMed ID: 2174966 [Abstract] [Full Text] [Related]
14. Interleukin-2 activated microglia engulf tumor infiltrating T cells in the central nervous system. Tamakawa N, Saio M, Suwa T, Ohe N, Yoshimura S, Iwama T, Shinoda J, Sakai N, Takami T. Int J Mol Med; 2004 Apr; 13(4):497-503. PubMed ID: 15010848 [Abstract] [Full Text] [Related]
15. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis. Takasugi K, Yamamura M, Iwahashi M, Otsuka F, Yamana J, Sunahori K, Kawashima M, Yamada M, Makino H. Arthritis Res Ther; 2006 Apr; 8(4):R126. PubMed ID: 16859503 [Abstract] [Full Text] [Related]
18. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15. Gri G, Chiodoni C, Gallo E, Stoppacciaro A, Liew FY, Colombo MP. Cancer Res; 2002 Aug 01; 62(15):4390-7. PubMed ID: 12154045 [Abstract] [Full Text] [Related]
19. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells. Park YJ, Song B, Kim YS, Kim EK, Lee JM, Lee GE, Kim JO, Kim YJ, Chang WS, Kang CY. Cancer Res; 2013 Sep 15; 73(18):5669-81. PubMed ID: 23867469 [Abstract] [Full Text] [Related]
20. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy. Berhanu A, Huang J, Alber SM, Watkins SC, Storkus WJ. Cancer Res; 2006 May 01; 66(9):4895-903. PubMed ID: 16651446 [Abstract] [Full Text] [Related] Page: [Next] [New Search]